Riskpilot← Back to searchSign inGet full accessEnfucell Oy
OYActiveY-tunnus 2867139-1As. 227Manufacture of batteries and accumulators · NACE 2720Est. 2017— employees
Revenue 2025
EUR 294K
+13% vs 2024
EBITDA margin
11.4%
+164% vs 2024
Equity ratio
-257.1%
Financial strength
Net profit 2025
EUR 34K
+173% vs 2024
| Revenue | EUR 294K | +13% |
| EBITDA | EUR 34K | +164% |
| Net profit | EUR 34K | +173% |
| Total assets | EUR 205K | +13% |
| Equity | EUR -528K | +6% |
| Employees | — | — |
Legal name
Enfucell Oy
Y-tunnus number
2867139-1
Legal form
Osakeyhtiö
NACE code
2720 · Manufacture of batteries and accumulators
Founded
6. marraskuuta 2017
Share capital
EUR 1 262 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on kemian ja sähköalan tuotteiden ja immateriaalisten oikeuksien, varsinkin ohuiden paristojen ja bioelektronisten järjestelmien, erityisesti polttokennojen, ja niihin liittyvien oheistarvikkeiden/materiaalien kehittäminen, valmistaminen, myynti ja hallinnointi. Lisäksi yritys voi ostaa, myydä ja omistaa kiinteistöjä, osakkeita sekä arvopapereita.
Address
As. 227
Phone
+3580415855733
Email
xiachang.zhang@enfucell.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 157 | 0 | 110 | 260 | 294 |
| Staff expenses | −121 | −0 | −90 | −93 | −28 |
| EBITDA | −100 | 0 | −55 | −52 | 34 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −100 | 0 | −55 | −52 | 33 |
| Net financials | 10 | 0 | 5 | 5 | 1 |
| Profit before tax | −91 | 0 | −50 | −47 | 34 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −91 | — | −50 | −47 | 34 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 360 | 0 | 282 | 182 | 205 |
| Equity | −405 | 0 | −515 | −562 | −528 |
| Long-term debt | 630 | 0 | 630 | 608 | 633 |
| Short-term debt | 134 | 0 | 168 | 135 | 100 |
| Total debt | 764 | 0 | 798 | 744 | 733 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20212025
Equity ratio
-257.1%
This company
38.2%
Market median
-773% vs market
20212025
Return on equity
3410200.0%
This company
18.4%
Market median
+18533596% vs market
20212025
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20212025
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TJ Audit | Audit | 2020 |
RR Deputy auditor | Deputy auditor | 2020 |
XC Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Enfucell Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Juhani Helle | Audit | 0 companies |
| Riku Rafael Vuorinen | Deputy auditor | 0 companies |
| Xia Chang Zhang | Chief Executive Officer | 0 companies |
| Antti Kalle Juhani Kivimaa | Board of Directors | 0 companies |
| Dongmei Wang | Board of Directors | 0 companies |